Page last updated: 2024-09-04

guvacoline and sk&f 100330-a

guvacoline has been researched along with sk&f 100330-a in 1 studies

Compound Research Comparison

Studies
(guvacoline)
Trials
(guvacoline)
Recent Studies (post-2010)
(guvacoline)
Studies
(sk&f 100330-a)
Trials
(sk&f 100330-a)
Recent Studies (post-2010) (sk&f 100330-a)
11072000

Protein Interaction Comparison

ProteinTaxonomyguvacoline (IC50)sk&f 100330-a (IC50)
Sodium- and chloride-dependent GABA transporter 1Homo sapiens (human)0.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, FE; Bondinell, WE; Dandridge, PA; Frazee, JS; Garvey, E; Girard, GR; Kaiser, C; Ku, TW; Lafferty, JJ; Moonsammy, GI1

Other Studies

1 other study(ies) available for guvacoline and sk&f 100330-a

ArticleYear
Orally active and potent inhibitors of gamma-aminobutyric acid uptake.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:5

    Topics: 4-Aminobutyrate Transaminase; Administration, Oral; Alkylation; Amino Acids; Animals; Brain; Carboxylic Acids; gamma-Aminobutyric Acid; Glutamate Decarboxylase; In Vitro Techniques; Male; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, GABA-A; Receptors, Neurotransmitter; Stereoisomerism; Synaptosomes

1985